Medeon Biodesign, Inc. (TPEX: 6499)

Medeon Biodesign Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 9, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,944	4,294	5,092	6,592	3,642	4,202
Market Cap Growth	-8.66%	-15.67%	-22.76%	80.99%	-13.33%	-9.09%
Enterprise Value	2,528	2,208	3,643	4,155	2,451	2,716
Last Close Price	42.80	46.65	54.79	70.07	38.83	44.53
PE Ratio	-	-3.56	-11.62	3.09	-18.46	-15.57
PS Ratio	18.60	21.88	17.07	95.60	29.60	9.26
PB Ratio	2.05	1.81	1.39	1.57	1.38	1.87
P/FCF Ratio	-5.38	-5.30	-8.46	-21.85	-21.25	-14.45
P/OCF Ratio	-5.76	-5.69	-11.04	-22.47	-24.08	-17.37
EV/Sales Ratio	11.93	11.25	12.21	60.25	19.91	5.98
EV/EBITDA Ratio	-3.58	-2.77	-7.93	-8.97	-8.62	-13.43
EV/EBIT Ratio	-3.40	-2.63	-7.47	-8.38	-7.17	-10.55
EV/FCF Ratio	-2.89	-2.72	-6.05	-13.77	-14.29	-9.34
Debt / Equity Ratio	0.10	0.08	0.05	0.01	0.19	0.05
Debt / FCF Ratio	-0.22	-0.23	-0.33	-0.10	-2.87	-0.41
Asset Turnover	0.08	0.06	0.07	0.02	0.04	0.20
Inventory Turnover	13.54	17.47	-	-	1.94	11.97
Quick Ratio	8.99	9.89	8.09	14.75	11.93	11.03
Current Ratio	9.21	10.05	8.25	14.91	12.25	11.41
Return on Equity (ROE)	-36.75%	-42.09%	-12.66%	-17.16%	-14.19%	-13.97%
Return on Assets (ROA)	-20.01%	-15.46%	-7.26%	-8.07%	-7.33%	-7.20%
Return on Capital (ROIC)	-21.43%	-16.34%	-7.55%	-8.42%	-7.76%	-7.72%
Earnings Yield	-20.58%	-28.06%	-8.52%	31.53%	-5.29%	-6.23%
FCF Yield	-22.16%	-18.87%	-11.82%	-4.58%	-4.71%	-6.92%
Dividend Yield	0.00%	-	0.87%	1.13%	-	-
Buyback Yield / Dilution	-0.06%	-0.02%	0.07%	-0.48%	-0.05%	-14.46%
Total Shareholder Return	-0.06%	-0.02%	0.94%	0.65%	-0.05%	-14.46%

Source: S&P Capital IQ. Standard template. Financial Sources.